Transformation of bacteria with plasmids is important because bacteria are used as the means for both storing and replicating plasmids. E. coli cells are more likely to incorporate foreign DNA if their cell walls are altered so that DNA can pass through more easily. Such cells are said to be "competent."
The global Competent E.coli market was valued at US$ 115 million in 2023 and is anticipated to reach US$ 151.8 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American market for Competent E.coli is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Competent E.coli is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Competent E.coli include Thermo Fisher Scientific Inc, Promega, Merck KGaA, New England Biolabs, Agilent Technologies, Takara Bio, Edge BioSystems, TransGen Biotech and Nanjing GenScript Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Competent E.coli, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent E.coli.
Report Scope
The Competent E.coli market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Competent E.coli market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Competent E.coli manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific Inc
Promega
Merck KGaA
New England Biolabs
Agilent Technologies
Takara Bio
Edge BioSystems
TransGen Biotech
Nanjing GenScript Biotechnology
GCC Biotech
SMOBIO Technology
QIAGEN N.V.
OriGene
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Molecular Cloning
Plasmid Extraction
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Competent E.coli manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Competent E.coli in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Competent E.coli 麻豆原创 Overview
1.1 Product Overview and Scope of Competent E.coli
1.2 Competent E.coli Segment by Type
1.2.1 Global Competent E.coli 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Competent E.coli Segment by Application
1.3.1 Global Competent E.coli 麻豆原创 Value by Application: (2024-2030)
1.3.2 Molecular Cloning
1.3.3 Plasmid Extraction
1.3.4 Other
1.4 Global Competent E.coli 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Competent E.coli Revenue 2019-2030
1.4.2 Global Competent E.coli Sales 2019-2030
1.4.3 Global Competent E.coli 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Competent E.coli 麻豆原创 Competition by Manufacturers
2.1 Global Competent E.coli Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Competent E.coli Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Competent E.coli Average Price by Manufacturers (2019-2024)
2.4 Global Competent E.coli Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Competent E.coli, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Competent E.coli, Product Type & Application
2.7 Competent E.coli 麻豆原创 Competitive Situation and Trends
2.7.1 Competent E.coli 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Competent E.coli Players 麻豆原创 Share by Revenue
2.7.3 Global Competent E.coli 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Competent E.coli Retrospective 麻豆原创 Scenario by Region
3.1 Global Competent E.coli 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Competent E.coli Global Competent E.coli Sales by Region: 2019-2030
3.2.1 Global Competent E.coli Sales by Region: 2019-2024
3.2.2 Global Competent E.coli Sales by Region: 2025-2030
3.3 Global Competent E.coli Global Competent E.coli Revenue by Region: 2019-2030
3.3.1 Global Competent E.coli Revenue by Region: 2019-2024
3.3.2 Global Competent E.coli Revenue by Region: 2025-2030
3.4 North America Competent E.coli 麻豆原创 Facts & Figures by Country
3.4.1 North America Competent E.coli 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Competent E.coli Sales by Country (2019-2030)
3.4.3 North America Competent E.coli Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Competent E.coli 麻豆原创 Facts & Figures by Country
3.5.1 Europe Competent E.coli 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Competent E.coli Sales by Country (2019-2030)
3.5.3 Europe Competent E.coli Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Competent E.coli 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Competent E.coli 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Competent E.coli Sales by Country (2019-2030)
3.6.3 Asia Pacific Competent E.coli Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Competent E.coli 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Competent E.coli 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Competent E.coli Sales by Country (2019-2030)
3.7.3 Latin America Competent E.coli Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Competent E.coli 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Competent E.coli 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Competent E.coli Sales by Country (2019-2030)
3.8.3 Middle East and Africa Competent E.coli Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Competent E.coli Sales by Type (2019-2030)
4.1.1 Global Competent E.coli Sales by Type (2019-2024)
4.1.2 Global Competent E.coli Sales by Type (2025-2030)
4.1.3 Global Competent E.coli Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Competent E.coli Revenue by Type (2019-2030)
4.2.1 Global Competent E.coli Revenue by Type (2019-2024)
4.2.2 Global Competent E.coli Revenue by Type (2025-2030)
4.2.3 Global Competent E.coli Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Competent E.coli Price by Type (2019-2030)
5 Segment by Application
5.1 Global Competent E.coli Sales by Application (2019-2030)
5.1.1 Global Competent E.coli Sales by Application (2019-2024)
5.1.2 Global Competent E.coli Sales by Application (2025-2030)
5.1.3 Global Competent E.coli Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Competent E.coli Revenue by Application (2019-2030)
5.2.1 Global Competent E.coli Revenue by Application (2019-2024)
5.2.2 Global Competent E.coli Revenue by Application (2025-2030)
5.2.3 Global Competent E.coli Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Competent E.coli Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific Inc
6.1.1 Thermo Fisher Scientific Inc Corporation Information
6.1.2 Thermo Fisher Scientific Inc Description and Business Overview
6.1.3 Thermo Fisher Scientific Inc Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Inc Competent E.coli Product Portfolio
6.1.5 Thermo Fisher Scientific Inc Recent Developments/Updates
6.2 Promega
6.2.1 Promega Corporation Information
6.2.2 Promega Description and Business Overview
6.2.3 Promega Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Promega Competent E.coli Product Portfolio
6.2.5 Promega Recent Developments/Updates
6.3 Merck KGaA
6.3.1 Merck KGaA Corporation Information
6.3.2 Merck KGaA Description and Business Overview
6.3.3 Merck KGaA Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck KGaA Competent E.coli Product Portfolio
6.3.5 Merck KGaA Recent Developments/Updates
6.4 New England Biolabs
6.4.1 New England Biolabs Corporation Information
6.4.2 New England Biolabs Description and Business Overview
6.4.3 New England Biolabs Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.4.4 New England Biolabs Competent E.coli Product Portfolio
6.4.5 New England Biolabs Recent Developments/Updates
6.5 Agilent Technologies
6.5.1 Agilent Technologies Corporation Information
6.5.2 Agilent Technologies Description and Business Overview
6.5.3 Agilent Technologies Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Agilent Technologies Competent E.coli Product Portfolio
6.5.5 Agilent Technologies Recent Developments/Updates
6.6 Takara Bio
6.6.1 Takara Bio Corporation Information
6.6.2 Takara Bio Description and Business Overview
6.6.3 Takara Bio Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Takara Bio Competent E.coli Product Portfolio
6.6.5 Takara Bio Recent Developments/Updates
6.7 Edge BioSystems
6.6.1 Edge BioSystems Corporation Information
6.6.2 Edge BioSystems Description and Business Overview
6.6.3 Edge BioSystems Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Edge BioSystems Competent E.coli Product Portfolio
6.7.5 Edge BioSystems Recent Developments/Updates
6.8 TransGen Biotech
6.8.1 TransGen Biotech Corporation Information
6.8.2 TransGen Biotech Description and Business Overview
6.8.3 TransGen Biotech Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.8.4 TransGen Biotech Competent E.coli Product Portfolio
6.8.5 TransGen Biotech Recent Developments/Updates
6.9 Nanjing GenScript Biotechnology
6.9.1 Nanjing GenScript Biotechnology Corporation Information
6.9.2 Nanjing GenScript Biotechnology Description and Business Overview
6.9.3 Nanjing GenScript Biotechnology Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nanjing GenScript Biotechnology Competent E.coli Product Portfolio
6.9.5 Nanjing GenScript Biotechnology Recent Developments/Updates
6.10 GCC Biotech
6.10.1 GCC Biotech Corporation Information
6.10.2 GCC Biotech Description and Business Overview
6.10.3 GCC Biotech Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GCC Biotech Competent E.coli Product Portfolio
6.10.5 GCC Biotech Recent Developments/Updates
6.11 SMOBIO Technology
6.11.1 SMOBIO Technology Corporation Information
6.11.2 SMOBIO Technology Competent E.coli Description and Business Overview
6.11.3 SMOBIO Technology Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.11.4 SMOBIO Technology Competent E.coli Product Portfolio
6.11.5 SMOBIO Technology Recent Developments/Updates
6.12 QIAGEN N.V.
6.12.1 QIAGEN N.V. Corporation Information
6.12.2 QIAGEN N.V. Competent E.coli Description and Business Overview
6.12.3 QIAGEN N.V. Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.12.4 QIAGEN N.V. Competent E.coli Product Portfolio
6.12.5 QIAGEN N.V. Recent Developments/Updates
6.13 OriGene
6.13.1 OriGene Corporation Information
6.13.2 OriGene Competent E.coli Description and Business Overview
6.13.3 OriGene Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.13.4 OriGene Competent E.coli Product Portfolio
6.13.5 OriGene Recent Developments/Updates
6.14 Lucigen
6.14.1 Lucigen Corporation Information
6.14.2 Lucigen Competent E.coli Description and Business Overview
6.14.3 Lucigen Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lucigen Competent E.coli Product Portfolio
6.14.5 Lucigen Recent Developments/Updates
6.15 Zymo Research
6.15.1 Zymo Research Corporation Information
6.15.2 Zymo Research Competent E.coli Description and Business Overview
6.15.3 Zymo Research Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zymo Research Competent E.coli Product Portfolio
6.15.5 Zymo Research Recent Developments/Updates
6.16 Bio-Rad Laboratories
6.16.1 Bio-Rad Laboratories Corporation Information
6.16.2 Bio-Rad Laboratories Competent E.coli Description and Business Overview
6.16.3 Bio-Rad Laboratories Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Bio-Rad Laboratories Competent E.coli Product Portfolio
6.16.5 Bio-Rad Laboratories Recent Developments/Updates
6.17 Bioline
6.17.1 Bioline Corporation Information
6.17.2 Bioline Competent E.coli Description and Business Overview
6.17.3 Bioline Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Bioline Competent E.coli Product Portfolio
6.17.5 Bioline Recent Developments/Updates
6.18 Delphi Genetics
6.18.1 Delphi Genetics Corporation Information
6.18.2 Delphi Genetics Competent E.coli Description and Business Overview
6.18.3 Delphi Genetics Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Delphi Genetics Competent E.coli Product Portfolio
6.18.5 Delphi Genetics Recent Developments/Updates
6.19 IBA GmBH
6.19.1 IBA GmBH Corporation Information
6.19.2 IBA GmBH Competent E.coli Description and Business Overview
6.19.3 IBA GmBH Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.19.4 IBA GmBH Competent E.coli Product Portfolio
6.19.5 IBA GmBH Recent Developments/Updates
6.20 Cell Applications
6.20.1 Cell Applications Corporation Information
6.20.2 Cell Applications Competent E.coli Description and Business Overview
6.20.3 Cell Applications Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Cell Applications Competent E.coli Product Portfolio
6.20.5 Cell Applications Recent Developments/Updates
6.21 BioDynamics Laboratory
6.21.1 BioDynamics Laboratory Corporation Information
6.21.2 BioDynamics Laboratory Competent E.coli Description and Business Overview
6.21.3 BioDynamics Laboratory Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.21.4 BioDynamics Laboratory Competent E.coli Product Portfolio
6.21.5 BioDynamics Laboratory Recent Developments/Updates
6.22 Scarab Genomics
6.22.1 Scarab Genomics Corporation Information
6.22.2 Scarab Genomics Competent E.coli Description and Business Overview
6.22.3 Scarab Genomics Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Scarab Genomics Competent E.coli Product Portfolio
6.22.5 Scarab Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Competent E.coli Industry Chain Analysis
7.2 Competent E.coli Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Competent E.coli Production Mode & Process
7.4 Competent E.coli Sales and 麻豆原创ing
7.4.1 Competent E.coli Sales Channels
7.4.2 Competent E.coli Distributors
7.5 Competent E.coli Customers
8 Competent E.coli 麻豆原创 Dynamics
8.1 Competent E.coli Industry Trends
8.2 Competent E.coli 麻豆原创 Drivers
8.3 Competent E.coli 麻豆原创 Challenges
8.4 Competent E.coli 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Thermo Fisher Scientific Inc
Promega
Merck KGaA
New England Biolabs
Agilent Technologies
Takara Bio
Edge BioSystems
TransGen Biotech
Nanjing GenScript Biotechnology
GCC Biotech
SMOBIO Technology
QIAGEN N.V.
OriGene
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
听
听
*If Applicable.
